This material may contain forward-looking statements, including but not limited to projections, estimates, targets, and opinions regarding future financial or operational performance. These statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially. Investors are cautioned not to place undue reliance on these statements.
FOR IMMEDIATE RELEASEContact: Jonathan Adam BarashEmail: press@oncofirmdiagnostics.comPhone: 516-900-2606Website: www.oncofirmdiagnostics.com OncoFirm Diagnostics Announces Launch and Opens First Round Funding Opportunities Up to $10 Million Revolutionizing Early Cancer Detection Through Rapid, Antigen-Based…
Investor Disclaimer The information provided by OncoFirm Diagnostics (“Company”) in this document, website, or presentation is for informational purposes only and does not constitute an offer to sell, or a…